Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
6 studies found for:    ABT-414
Show Display Options
Rank Status Study
1 Completed A Study of ABT-414 in Subjects With Solid Tumors
Condition: Squamous Cell Tumors
Intervention: Drug: ABT-414
2 Active, not recruiting Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Interventions: Drug: ABT-414;   Drug: Temozolomide;   Radiation: Whole Brain Radiation
3 Recruiting Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma
Conditions: Malignant Glioma;   Glioblastoma
Interventions: Drug: ABT-414;   Drug: Temozolomide;   Radiation: Whole Brain Radiation
4 Available Expanded Access to ABT-414
Condition: Cancer
Intervention: Drug: ABT-414
5 Recruiting A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Conditions: Glioblastoma;   Gliosarcoma
Interventions: Drug: ABT-414;   Radiation: Radiation;   Drug: Temozolomide;   Drug: Placebo for ABT-414
6 Recruiting Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas
Condition: Glioblastoma Multiforme
Interventions: Drug: ABT-414;   Drug: Lomustine;   Drug: Temozolomide

Study has passed its completion date and status has not been verified in more than two years.